Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.89 EUR | -0.26% | -1.53% | +5.45% |
Mar. 26 | Atrys Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Atrys Health, S.A. announced that it has received ?13.3 million in funding | CI |
Sales 2024 * | 220M 239M | Sales 2025 * | 236M 256M | Capitalization | 296M 321M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.17M | Net income 2025 * | 4M 4.34M | EV / Sales 2024 * | 2.13 x |
Net Debt 2024 * | 173M 188M | Net Debt 2025 * | 160M 174M | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
-119
x | P/E ratio 2025 * |
70.9
x | Employees | 1,865 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.57% |
1 day | -0.77% | ||
1 week | -1.53% | ||
Current month | +37.23% | ||
1 month | +31.19% | ||
3 months | +26.47% | ||
6 months | -0.26% | ||
Current year | +5.45% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 07-06-12 | |
Director of Finance/CFO | - | 15-07-31 | |
Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 48 | 16-01-31 | |
Director/Board Member | - | - | |
Aurora Catá Sala
BRD | Director/Board Member | 60 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 3.89 | -0.26% | 9 467 |
24-05-22 | 3.9 | +1.30% | 145,680 |
24-05-21 | 3.85 | -7.89% | 423,370 |
24-05-20 | 4.18 | -0.71% | 320,046 |
24-05-17 | 4.21 | +7.12% | 430,218 |
Delayed Quote BME, May 23, 2024 at 04:32 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.45% | 321M | |
+17.63% | 83.4B | |
+0.21% | 27.04B | |
-11.48% | 16.96B | |
-0.43% | 16.86B | |
+2.89% | 15.76B | |
+1.25% | 12.76B | |
+73.23% | 13.33B | |
+72.58% | 12.74B | |
+1.71% | 12.32B |
- Stock Market
- Equities
- ATRY Stock